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Summary: The catalytic activity and the stability of prostatic acid phosphatase were studied with respect to
pH and temperature:
1. Enzymatic activity in serum decreases with time, and the rate of decrease depends on pH and temperature.
Half life times were estimated.
2. To preserve at least 90% of its original activity, serum must be cooled äs soon äs possible below room
temperature and/or the pH must be lowered to 6.
3. Considering the effect of pH on side reactions and kinetic parameters, a pH of 5.2 is recommended for
the assay.
4. Between 25 and 37 °C, the value for ATmapp, in the absence of alcohols, is constant within the limits of
error. In the presence of alcohols there is a significant increase of ÄTmapp at lower temperatures, and higher
Substrate concentrations are needed to avoid nonsaturation of the enzyme. vmax increases with temperature.
Inactivation is observed above 45 °C, especially in the presence of alcohols.
5. The Arrhenius plot shows a strict linear regression between 20 °C and 40 °C, in the presence or absence
of l,4^butanediol, 1,5-pentanediol qr 1,6-hexanediol.
6. Temperature conversioii factors for catalytic activity were calculated to be: 1.33 (25 to 30 °C), 1.96 (25 to
37 °C) and 1.47 (30 to 37 °C).
Introduction T , - . , - , A f -In the case of secretory acid phosphatases of the
Proportionality between quantity of enzyme and prostate it has been shown that at least 15 different
catalytic activity is an important prerequisite for the isoenzymes can be separated (1). So far, the physio-
determinätion of catalytic activity äs an aid to elinical logical Substrates of these phosphatases are still un-
diagnosis. Temperature is one of the important fac- known. Thus, determination of acid phosphatase de-
tprs influencing catalytic activity and has subse^ pends on artificial Substrates, e.g. /?-nitrophenyl
quently to be controlled. Acid phosphatases (EC phosphate or naphthyl phosphate, the latter being
3.1.3.2) may derive in humans not only froin different used in a continupus method developed by Hillmann
organs but even ffom different compartments within (2) with continuous monitoring. In an attempt to
a given cell e. g. from lysosomes or secretory granules. optimize this method our paper deals with tempera-
^__ ture dependenee of the enzymatic reaction and with
') Teil der Dissertation (D 26) the stability of the enzyme in serum.
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With respect to clinical relevance and practicability,
immunologic tests (RIA äs well äs ELISA), even with
monoclonal antibodies, are not superior to enzymatic
tests (3, 4). In addition, the cost and time for the
immunologic determination of acid phosphatase
exceed those for the measurement of enzymatic activ-
ity. Thus, optimization and standardization of the




Fast red TR salt (Sigma F 1500); 1-naphthyl phosphate p.a.
(Serva 30130); bovine serum albumin, lyophil. (Serva 11930
control E; other control batches did not match the requirements
of the test); 1,4-butanediol (Merck 801532); 1,6-hexanediol
(Merck 804308); 1,5-pentanediol (Fluka 76890); sodium acetate
(Merck 6267). All other reagents were of the best quality
available. Freshly clotted blood was centrifuged, immediately
acidified by addition of 2 mol/1 acetic acid (20 ml/l) and stored
at 4 °C for routine use. In all other experiments pH was cor-
rected äs specified.
Acid phosphatase was derived from pooled human serninal
plasma, which was stored at -18°C. Repeated freezing and
thawing with removal of precipitates resulted in a solution in
which enzymatic activity was stable for over 10 years. Dilution
of the enzyme was performed using buffer with the addition of
0.6 g/l albumin.
In this study sera from patients with elevated catalytic concen-
tration of acid phosphatase were used äs well äs sera enriched
with prostatic acid phosphatase from seminal plasma. Some of
the experiments were performed with diluted acid phosphatase
from seminal plasma äs indicated. No determinations involving
Inhibition by tartrate were performed within this study.
Reactions were carried out in 0.4 mol/1 sodium acetate buffer
prepared at 25 °C. The pH/temperature gradient of this buffer is
0.003 pH/ °C. All Solutions except buffer were freshly prepared.
Enzyme catalytic concentration is derived in U/l = 1176
min using a molar lineic absorbance of the chromophore of
6390nm = 1-36 m2/mol (5). Calculations of kinetic data were
made by the use of the kinfit program äs described (6).
Results and Discussion
·· r
Stability of prostatic acid phosphatase in
serum
Enzymatic activity of prostatic acid phosphatase in
serum tends to decrease durmg storage (7, 8). This
process is dependent on time, temperature and pH
value. We found thät iriactivatioii of acid phosphatase
and of the enzyme in serum followed first order
kinetics ät all pH values and temperatur.es studied.
This represents an addition to the existing data on
purified prostatic acid phosphatase at single pH val-
ues (9,10). InactiVation of acid phosphatase is plotted
in figure l, showing the log of half life times of the
enzyme versus temperature. The data for the enzyrne
at pH 5.2 and enzyme iri serum at pH 6.0 and 7.0
show almost parallel plots, whereas the slope at pH
8.2 is considerably less. This may indicate conforma-
tional changes in protein structure near to or slightly
above physiological pH values, which facilitate dena-
turation. The same conchision may be drawn from
Arrhenius plots which result in decreasing energies of
activation for denaturation (täb. 1) with rising pH.
These results might also explain the shörter half life
times of acid phosphatase in bloöd during fever with
concomitantly reduced enzyme activity in serum.
Instruments
Reaction kinetics were followed using a Perkin Eimer Double
Beam Spectrophotometer 124 with recorder 56 or a PYE Uni-
cam 8800 Spectrophotometer (Philips) with 6 changeable cuvet-
tes. Temperature was controlled to 0.1 °C in a thermostated
cuvette holder by a Lauda ultra thermostat.
Procedure
In order to facilitate performance of varying reaction conditions
each assay consisted of
l ml naphthyl phosphate (different concentrations) in sodium
acetate buffer (0.4 mol/1, pH 5.2)
l ml 6.0 mmol/1 Fast Red TR + 9 g/l albumin in sodium
acetate buffer (0.4 mol/1, pH 5.2)
l ml sodium acetate buffer (0.4 mol/1, pH 5.2) with other
components (e. g. alcohols) added.
0.2 ml serum or diluted acid phosphatase.
The components were mixed without addition of serum, and
absorbance was recorded for 10 minutes at 390 nm in l cm
cuvettes (blank value). Serum was then added, and the reaction
was recorded for 20 min at 390 nm. After the lag phase of 5











Fig. 1. Half life times of denaturation öf prostatic acid phos-
phatase versus temperature and pH.
O — O acid phosphatase from seminal plasma in so=
dium acetate buffer pH 5.2
ö—o acid phosphatase in serum adjusted to pH 6.0
— acid phosphatase in serum adjusted to pH 7.0
— acid phosphatase in serum adjusted to pH 8.2
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380 ± l kJ/mol (prostatic enzyme)
366 ± 2 kJ/mol (in serum)
348 ± 4 kJ/mol (in serum)
260 ± 20 kJ/mol (in serum)
Sampling and storage of serum
In clinical chemical determinations tbe enzymatic
activity of prostatic acid phosphatase at the time of
assay should not deviate greatly from the enzymatic
activity at the time of blood sampling. In this respect
the values of flgure l demonstrate the importance of
controlling pH and temperature during storage of
serum. In order to guarantee that only sera are as-
sayed in which acid phosphatase is inactivated to less
then 10%, storage temperature must be kept below
a certain value and pH must be adjusted. In figures
2 a and 2 b curves are drawn where at least 90% of
the original activity is retained with respect to storage
50
24
Fig. 2. Permitted time of storage with less than 10% loss of
enzymatic activity in dependence on temperature.
a) l: prostatic acid phosphatase
2: serum pH 6.0
3: serum pH 7.0
4: serum pH 8.2
b) serum at pH 7.0
time and temperature at a given pH. For a storage
time of 5 or 24 hours, 90% activity curves show
optimal temperatures that depend on pH (fig. 3).
Since pH of serum in open vessels is raised rather
fast (0.5 pH units within the first hour) the time
between drawing blood from the patient, clotting and
removal of serum is most critical. Thus reduction of
clotting time to 15 minutes by using thrombin coated
tubes, s suggested by Theodorsen (11), clotting in
closed vessels, immediate Separation of serum, pH
adjustment and proper temperature control of the
serum sample can not only prevent inactivation of
prostatic acid phosphatase considerably but also di-
minish an increase of phosphatase activity from unin-
tended sources such s platelets and leukocytes.
Dependence of enzymatic activity on pH
A clear maximum of activity is observed at 42 °C at
pH 5.6. This maximum levels off below 38 °C, s




5.0 6.0 7.0 8.0 9.0
oH
Fig. 3. Influence of temperature and pH on storage. At least
90% of enzymatic activity is retained within 5 hours























Fig. 4. pH-optimum at different temperatures s indicated.
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buffer and the temperature used, pH optima ranging
from pH 4.9 (7), 5.2 (12), 5.5 (13), 5.6 (14), 5.7 (15)
to pH 6.0 (16,17) have been reported. But all authors
agree that prostatic acid phosphatase shows a broad
Optimum. The difference of enzymatic activity be-
tween pH 5.6 and 5.2 is less than 4%. The indicatof
reaction with fast red has a shorter lag phase at pH
5.6 than at pH 5.2 (5, 18). But the formatiert of
unspecific chromophores from the blank value s well
s from the reaction of proteins with fast red is
considerably lower at pH 5.2 (fig. 5) and the influence
of bilirubin is minimized at pH 5.2 (19).
Kinetic studies of acid phosphatase reVealed that the
monoanionic form of the Substrate takes part in the
kinetically productive reaction step indicated by k2





4.5 5.0 5,5 6.0
pH
Fig. 5. „Blank values" in serum pf healthy blood donors in
dependence on pH and temperature,
lower curve: 25 °C
middle curve: 30 °C
upper curve: 37 °C
ROH











= alcohol or water
In figure 6 ATmapp is drawn in dependence on pH.
While inapp increases strongly with pH, a slight de-
crease is observed after correction for Substrate ion-
ization using ρΚΛ = 5.85 for 1-naphthyl phosphate
(22). Substrate Saturation of the enzyme thus strongly
depends on Substrate ionization. Since at pH 5.2
about 82% of the Substrate is in the monoionic form
and since this value drops to 64% at pH 5.6, and
42% at pH 6.0, it is clear that a lower pH value for
the assay of prostatic acid phosphatase is preferable.
From this consideration and the reasons outlined
above, a pH of 5.2 is recommended for assay condi-
tions.
Dependence of enzymatic activity on tem-
perature
The maximal velocity of reaction (vmax) increases ex-
ponentially from 10 to 50 °C. The addition of diols
accelerates the enzymatic reaction. But enzyme inacti-
vation occurs at higher temperatures in the presence
of 1,5-pentanediol and 1,6-hexanediol at the concen^











Fig. 6. Km of prostatic acid phosphatase in dependence on pH
0-0 *mapp
Δ — Δ Km corrected for Substrate ionization
The binding constant rmapp s shown in figure 8
decreases with temperature. Without addition of alco-
hols it remains relatively constant between 25 and
37 °C. This is similar to the observations with /?-
nitrophenyl phosphate (20). In the presence of diols,
however, the temperature dependence is considerable
even between 25 and 37 °C. In consequence, in the
presence of diols it is difficult to, cpcapare results
assayed at different temperatures if Substrate cpncen-
trations are not adjusted to Saturation conditions.
This is especially valid if the same kit is used at
different temperatures.
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Fig. 1. Dependence of vmvi on temperature
Δ — Δ enzyme without addition of alcohol
o—o in presence of 0.25 mol/1 1,4-butanediol
D — D in presence of 0.25 mol/1 1,5-pentanediol
O — O in presence of 0.25 mol/1 1,6-hexanediol
Energy of activation
It is well known that the Arrhenius plots of several
enzymes do not show linear regressions between 20
and 40 °C, e. g. glutamate dehydrogenase (23), amino-
transferase, lactate dehydrogenase, creatine kinase
(24), all being enzymes which need several cofactors
(25). But even alkaline phosphatase does not show a
linear regression in the Arrhenius plot (24). This has
been ascribed to the fact that alkaline phosphatase
c nsists of several isoenzymes. Although prostatic
acid phosphatase also c nsists of several isoenzymes
a strict linear regression is derived s shown in figure
9 (upper curve). One of the reasons may be that
prostatic acid phosphatase mainly c nsists of isoen-
zyme 2 according to 1. c. (16). But if Substrate satura-
tion is not achieved, prostatic acid phosphatase also
fails to show linear regression in the Arrhenius plot,
as demonstrated in figure 9. This n ght explain devia-
tion from a straight line in multicomponent Systems
where Substrate Saturation for all components can
hardly be achieved. If assays of acid phosphatase aire
performed in the presence of diojs, deviations from
the straight line are likewise observed when using an
extended. temperature r nge (fig. 10). Therefore we
have calcul ted the energy of activation between 22
and 42 °C In the case of acid phosphatase without
addition of alcohols no significantly different value
is obtained when the energy of activation is calcul ted
using the r nge between 4 and 50 °C.
The energy of activation has been ascribed to the rate
limiting dephosphorylatipn Step in Eq. l (20). The









Fig. 8. Dependence of Kmiipp on temperature
Δ — Δ enzyme without addition of alcohol
D —D in presence of 0.25 mol/1 1,4-butanediol
o —o in presence of 0.25 mol/1 1,5-pentanediol
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Fig. 9. Arrhenius plots of prostatic acid phosphatase-catalysed
hydrolysis of l^naphthyl phosphate at different sub-
strate concentrations.
curves from bottom to top: 0.05, 0.1, 0.25, 0.5, 2.0, 5.0








3.0 3.1 3.2 313
Fig. 10. Arrhenius plots of prostatic acid phosphatase-catalysed
hydrolysis of 1-naphthyl phosphate at vmax
Δ — Δ enzyme without alcohol
o-o in presence of 0.25 mol/11,4-butanediol
D-^D in presence of 0.25 mol/11,5-pentanediol
O-O in presence of 0.25 mol/11,6-hexanediol
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our results. Table 2 shows that alcohols äs acceptors
of phosphate instead of water decrease the energy of
activation. With 1,5-pentanediol a minimum of en-
ergy of activation is reached.
The results of figure 8 stress the importance of sub-
strate Saturation. But without going into details of
reaction kinetics, the possibility of specific changes
of the dephosphorylation mechanism cannot be ex-
cluded from our data (fig. 10). To avoid unnecessarily
high Substrate and fast red concentrations with a
concomitant increase in production of unspecific
chromophores, we suggest that measurements of the
catalytic activity of prostatic acid phosphatase should
be performed without addition of alcohols, despite
the fact that the enzyme is activated by diols.
The straight line of the Arrhenius plot (fig. 10) without
addition of alcohols enables the application of con-
version factors in order to recalculate and compare
results from assays performed at different tempera-
tures. These, conversion factors are shown in table 3.
Since slightly different results are obtained if these
conversion factors are applied to sera containing non-
prostatic acid phosphatase, care should be taken in
using these factors without mentioning the fact of
recalculation.
Tab. 2. Energies of activation for prostatic acid phosphatase-
catalysed hydrolysis of 1-naphthyl phosphate.
Prostatic enzyme 43.0 kJ/mol
in presence of 0.25 mol/11,4 butanediol 39.0 kJ/mol
in presence of 0.25 mol/11,5 pentanediöl 37.0 kJ/mol
in presence of 0.25 mol/11,6 hexanediol 38.6 kJ/mol
Tab. 3. Conversion factors of catalytic activity measured at
different temperatures.
To obtain activity at















Although it seems feasible from our data to calculate
and compare conversion factors for acid phosphatase
activity in the absence and presence of alcohols (e. g.
pentanediöl), we omit these factors in our paper,
because they are strongly dependent the source of
acid phosphatase in the serunij and on the alcohol
concentration used.
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